BJP’s surprise return to power in Haryana, different power centres within farmer unions, and Saini govt’s MSP gambit are some ...
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
Notably, Soludo visited Kanu at the DSS facility, where he offered to take him on administrative bail and assured authorities ...
Agitation caused by Alzheimer’s disease currently has one FDA-approved therapy, but that drug brings serious safety risks. An Axsome Therapeutics drug has mixed results from its latest slate of ...
Dec 30 (Reuters) - Axsome Therapeutics (AXSM.O), opens new tab said on Monday it would seek marketing approval next year for its oral drug to treat agitation in patients with Alzheimer's disease ...
The senior counsel and Samajwadi Janparishad state president, Adv Vishnu Dhoble’s book ‘Shishvruti Vadhiche Sansadiya Andolan ...
Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.
The doctor would use AXS-05 just long enough to control patients’ agitation, the firm adds. It keeps an Outperform rating on Axsome with a $140 price target Published first on TheFly – the ...
In a video Karsanbhai Patel of the Nirma group is purportedly heard saying that only those who led the protests reaped ...